BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 10, 2007
View Archived Issues
Interleukins in dermatology
Read More
Kosan receives SPA for TIME-1 trial of tanespimycin in multiple myeloma
Read More
Extinction of learned responses to fear regulated by Cdk5 signaling in hippocampus / News in Context
Read More
Late phase II trials for ART-123 begin
Read More
ThromboGenics and BioInvent state positive results from TB-402 phase I clinical trial
Read More
Fennobon launches cholesterol-lowering chewing gum with Reducol
Read More
Athersys completes name change
Read More
Update on ReNeuron's ReN-001 stem cell therapy for stroke
Read More
Tikvah and Chakra to codevelop four novel antipsychotic compounds
Read More
Update on Alba Therapeutics' AT-1001 IND for type 1 diabetes
Read More
Health Canada makes changes in Ketek indications
Read More
Sirtris and NIA sign CRADA for SIRT1 activators in aging
Read More
Two-year collaboration agreement signed by Aradigm and CyDex
Read More
PAR-1 inhibition by SCH-602539 shows antithrombotic effects in vivo
Read More
MHLW approves Taiho's antimetabolite TS1 capsules for biliary cancer
Read More
Selective tissue targeting with novel siRNA delivery technology
Read More
AtheroGenics announces new data on AGI-1067 in diabetes
Read More
Update on Salix's pipeline
Read More
Nabi reports interim results from phase IIb trial of NicVAX
Read More
Positive results for Plethora Solutions' phase II study of PSD-597 for interstitial cystitis
Read More
Studies advance clinical development of almorexant for insomnia
Read More
New antiglaucoma agents jointly imparted by NicOx and Pfizer
Read More
Recent Pfizer patents disclose novel antibacterial agents
Read More
New agents for treating neurological disorders disclosed in recent patent literature
Read More